SG Americas Securities
CBIO

SG Americas Securities’s Crescent Biopharma CBIO Stock Holding History

SG Americas Securities’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-188
Closed -$56K – 3027
2024
Q1 		$56K Buy
+188
New +$56.2K ﹤0.01% 2730
2021
Q1 		– Sell
-147
Closed -$55K – 3379
2020
Q4 		$55K Buy
+147
New +$51.5K ﹤0.01% 3131
2020
Q3 		– Sell
-185
Closed -$70K – 2985
2020
Q2 		$70K Buy
185
+57
+45% +$16.1K ﹤0.01% 3469
2020
Q1 		$29K Buy
+128
New +$48.9K ﹤0.01% 3254
2018
Q1 		– Sell
-62
Closed -$103K – 3356
2017
Q4 		$103K Buy
+62
New +$82K ﹤0.01% 2842

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return